<style face="normal" font="default" size="100%">Does Angiotensin-Converting Enzyme Inhibitor and beta-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink</style>

Drupal-Bibcite

31<style face="normal" font="default" size="100%">Does Angiotensin-Converting Enzyme Inhibitor and beta-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink</style><style face="normal" font="default" size="100%">Does Angiotensin-Converting Enzyme Inhibitor and beta-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink</style>